The Journal of Clinical Endocrinology & Metabolism · 1985 · 88 citations · 25 references
MedicineEndocrinologyPharmacologyHormone BiochemistryNeuroendocrinologyPharmacodynamicsGrowth HormoneHormone-secreting TumorsPituitary Gland FunctionPituitary HormonesPituitary TumorsFunctioning Pituitary AdenomasPituitary Hormone ReceptorsPituitary Peptide HormonesProlactin-secreting AdenomasSomatostatin AnaloguesSomatostatin FunctionSubstance P PharmacologyVasoactive Intestinal Peptide Signaling
[125I-Tyr]Somatostatin [( 125I-Tyr]SRIH) binding was found in 11 GH-secreting pituitary adenomas [Kd = 0.46 +/- 0.15 (+/- SE) nM; maximum binding, 165 +/- 35 fmol/mg protein). This binding was specific, since it was displaced by somatostatin-14 (SRIH-14), N-Tyr-SRIH-14, and SRIH-28. In contrast, a number of peptides and drugs not structurally related to SRIH, such as bombesin, dopamine, LHRH, met-enkephalin, naloxone, neurotensin, secretin, substance P, TRH, or vasoactive intestinal peptide, did not affect [125I-Tyr]SRIH binding. [125I-Tyr]SRIH specific binding also was found in PRL-secreting pituitary adenomas. The kinetic characteristics of the specific binding were similar to those of GH-secreting adenomas. However, maximal binding was one quarter that of GH-secreting adenomas (37 +/- 9 fmol/mg protein). In contrast, nonsecreting (chromophobe) tumors were devoid of any specific binding. Finally, in acromegaly, the density of [125I-Tyr]SRIH-binding sites in the adenomas was negatively correlated with plasma GH levels before surgery (r = -0.80). This suggests that somatostatinergic control is involved in GH secretion in acromegalic patients.
25
Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone
Paul Brazeau, Wylie Vale, Roger Burgus et al. · Science · 1973 · 3.5K citations
Effects of Somatostatin on the Secretion of Thyrotropin and Prolactin
Wylie Vale, Catherine Rivier, Paul Brazeau et al. · Endocrinology · 1974 · 299 citations